Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter
The field of ophthalmology is constantly evolving with new technologies and treatments emerging every year. In the next decade, we can expect even more advancements that will revolutionize the way we approach eye care. Here are the top 10 eye…

Astellas Pharma, a Japanese drugmaker, announced the acquisition of Iveric Bio, a pharmaceutical company that is currently in the late stages of developing a geographic atrophy drug. The acquisition is valued at $5.9 billion, and under the terms of the…

In a recent survey conducted on LinkedIn by the Ophthalmology Breaking News (OBN), ophthalmology professionals were asked to identify the emerging technology they believed held the most promise for improving surgical outcomes in their field. The results shed light on…

Oertli Instrumente announced that the OS 4 surgical platform is now available with four new features for greater comfort in retinal, glaucoma and cataract surgery. Oertli’s OS 4 platform is a powerful, multifaceted system designed for retinal, glaucoma, and cataract…

Cataract surgery has undergone remarkable advancements, leading to significant improvements in patient outcomes and revolutionizing the field of ophthalmology. From advanced surgical techniques to innovative intraocular lens (IOL) options, this article explores the top six breakthroughs in cataract surgery that…

Iris prolapse is a condition wherein the iris, the colored part of the eye responsible for controlling the amount of light entering the eye, protrudes out through a surgical wound or a traumatic wound in the cornea or sclera. This…

Ophthalmologists, often referred to as eye doctors, are healthcare professionals who specialize in the diagnosis, treatment, and management of eye diseases and disorders. While we may visit them for routine eye exams or specific vision concerns, the world of ophthalmology…

The US Food and Drug Administration (FDA) has taken action to update the warning label on Horizon Pharmaceutical’s TEPEZZA, a drug used to treat thyroid eye disease (TED), to include the risk of hearing impairment or loss. The recent addition…

The Otus personal eye-trainer, developed by Edenlux, has launched a campaign through Indiegogo. The device uses training called Vision Therapy to relieve the stress of the eyes. Vision Therapy is an exercise that repeats the contraction and relaxation of the…

AbbVie, the parent company of Allergan, has announced that the FDA has granted approval for the use of Vuity (pilocarpine HCl ophthalmic solution) 1.25% twice a day in adults suffering from presbyopia. The second dose, consisting of an additional drop…